2022. A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus. Journal of Pharmaceutical Negative Results. 13, 2 (Jun. 2022), 7–12.